Erratum to: Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines (J Cell Biochem, (2011), 112, (2115-2124), 10.1002/jcb.23132);Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2115-2124

  Dudzik, Paulina ^a   Dulińska Litewka, Joanna ^a   Wyszko, Eliza ^b   Jȩdrychowska, Patrycja ^a   Opałka, MacIej ^a   Barciszewski, Jan ^b   Laidler, Piotr ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

Apoptosis; Breast; Cancer; Caspase 3; Kinetin riboside; Melanoma; Prostate

Indexed keywords

ADENOSINE DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE; CASPASE 3; CYTOCHROME C; KINETIN RIBOSIDE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL STRAIN LU1205; CELL STRAIN MCF7; CELL STRAIN T47D; CELL STRAIN WM793; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY TEST; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 79960344539     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24991     Document Type: Erratum

References (38)

1. Barciszewski J, Massino F, Clark BFC,. 2007. Kinetin-A multiactive molecule. Int J Biol Macromol 40: 182-192. (Pubitemid 46215728)
2. Budihardjo I, Olivier H, Lutter M, Luo X, Wang X,. 1999. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290. (Pubitemid 32250377)
3. Cabello CM, Bair WB III, Ley S, Lamore SD, Azimian S, Wondrak GT,. 2009. The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines. Biochem Pharmacol 77: 1125-1138.
4. Cain K, Bratton SB, Langlais C, Walker G, Brown DG, Sun XM, Cohen GM,. 2000. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem 275 (9): 6067-6070. (Pubitemid 30129888)
5. Cheong J, Goh D, Yong JWH, Tan SN,. 2009. Inhibitory effect of kinetin riboside in human hapatoma, HepG2. Mol Biosys 5: 91-98.
6. Choi BH, Kim W, Wang QC, Kim DC, Tan SN, Yong JWH, Kim KT, Yoon HS,. 2008. Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells. Cancer Lett 261: 37-45.
7. McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX, Thompson CB, Hay N, Chandel NS,. 2002. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 22: 94-104. (Pubitemid 33144259)
8. Danial NN, Korsmeyer SJ,. 2004. Cell death: Critical control points. Cell 116: 205-219. (Pubitemid 38167313)
9. Decaudin D, Marzo I, Brenner C, Kroemer G,. 1998. Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy. Int J Oncol 12 (1): 141-152. (Pubitemid 28027240)
10. Dulińska J, Gil D, Zagajewski J, Hartwich J, Bodzioch M, Dembinska-Kiec A, Langmann T, Schmitz G, Laidler P,. 2005. Different effect of beta carotene on proliferation of prostate cancer cells. Biochim Biophys Acta 1740: 189-201. (Pubitemid 40798229)
11. Earnshaw WC, Martins LM, Kaufman SH,. 1999. Mammalian caspases: Structure, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424. (Pubitemid 29449198)
12. Er E, Olivier L, Cartron PF, Juin P, Manon S, Vallette FM,. 2006. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 1757: 1301-1311. (Pubitemid 44442128)
13. Fasanaro P, Magenta A, Zaccagnini G, Cicchillitti L, Fucile S, Eurebi F, Biglioli P, Capogrossi MC, Martelli F,. 2002. Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress. FASEB J 20: E503-E515.
14. Fesik SW, Shi Y,. 2001. Controlling caspases. Science 294: 1477-1478.
15. Fulda S, Debatin KM,. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 (34): 4798-4811. (Pubitemid 44187627)
16. Ge L, Yong JW, Goh NK, Chia LS, Tan SN, Ong ES,. 2005. Identification of kinetin and kinetin riboside in coconut (Cocos nucifera L.) water using a combined approach of liquid chromatography-tandem mass spectrometry, high performance liquid chromatography and capillary electrophoresis. J Chromatogr B 829: 26-34. (Pubitemid 41773461)
17. Green DR, Kroemer G,. 2004. The pathophysiology of mitochondrial cell death. Science 305: 625-629.
18. Griffaut B, Bos R, Maurizis JC, Madelmont JC, Ledoight G,. 2004. Cytotoxic effects of kinetin riboside on mouse, human, and plant tumor cells. Int J Biol Macromol 34: 271-275. (Pubitemid 39220863)
19. Ishii Y, Hori Y, Sakai S, Honma Y,. 2002. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentation-inducing hormones. Cell Growth Differ 13: 19-26. (Pubitemid 34106796)
20. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC,. 1993. Bcl-2 blocks apoptosis in cell lacking mitochondrial DNA. Nature 361: 365-369. (Pubitemid 23041631)
21. Janicke RW, Sprengart ML, Wati MR, Porter AG,. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360. (Pubitemid 28183012)
22. Kamada S, Kikkawa U, Tsujimoto Y, Hunter T,. 2005. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J Biol Chem 280: 857-860.
23. Krautwald S, Ziegler E, Rolver L, Linkermann A, Keyser KA, Steen P, Wollert KC, Korf-Klingebiel M, Kunzendorf U,. 2010. Effective blockage of both the extrinsic and intrinsic pathways of apoptosis in mice by TAT-crmA. J Biol Chem 285 (26): 19997-20005.
24. Kumar S, Vaux DL,. 2002. Apoptosis. A Cinderella caspase takes center stage. Science 297 (5585): 1290-1291. (Pubitemid 34913159)
25. Laidler P, Dulinska J, Mrozicki S,. 2007. Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines? Arch Biochem Biophys 462 (1): 1-12. (Pubitemid 46755138)
26. Lailer L, Carton PF, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette FM,. 2007. Bax action and mitochondrial insertion during apoptosis. Apoptosis 12: 887-896. (Pubitemid 46653297)
27. Marzo I, Naval J,. 2008. Bcl-2 family members as molecular targets in cancer therapy. Biochem Pharmacol 76: 939-946.
28. Mlejnek P, Dolezel P,. 2005. Apoptosis induced by N6-substituted derivatives of adenosine is related to intracellular accumulation of corresponding mononucleotides in HL-60cells. Toxicol Vitro 19: 985-990. (Pubitemid 41563237)
29. Murray AL,. 2004. Recycling the cell cycle: Cyclins revisited. Cell 116: 221-234.
30. Saelens X, Festjens N, Walle LV, van Gurp M, van G, Vandenabeele P,. 2004. Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861-2874. (Pubitemid 38638848)
31. Shi Y,. 2002. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9: 459-470. (Pubitemid 34273778)
32. Shiroff EH, Snydler C, Chandel NS,. 2007. Bcl-2 family members regulate anoxia-induced cell death. Antioxid Redox Signal 9: 1405-1409. (Pubitemid 47255020)
33. Tiedemann RE, Mao X, Shi CX, Zhu YX, Palmer SE, Sebag M, Marler R, Chesi M, Fonseca R, Bergsagel PL, Schimmer AD, Stewart AK,. 2008. Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. J Clin Invest 118: 1750-1764. (Pubitemid 351632378)
34. Utikal J, Udart M, Leiter K, Peter RU, Krahn G,. 2005. Additional cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma. Int J Oncol 26: 597-605.
35. von Loo G, Saelens X, Matthijssens F, Schotte P, Beyaert R, Declercq W, Vandenabeele P,. 2002. Caspases are not localized in mitochondria during life or death. Cell Death Differ 9 (11): 1207-1211. (Pubitemid 35331767)
36. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW,. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: 806-819. (Pubitemid 28150882)
37. Xiong Y, Connolly T, Futcher B, Beach D,. 1991. Human D-type cyclin. Cell 65: 691-699.
38. Zheng TS, Schlosser SF, Dao T, Hingorani R, Crispe IN, Boyer JL, Flavell RA,. 1998. Caspase 3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc Natl Acad Sci USA 95: 13618-13623. (Pubitemid 28523021)